Concepedia

Maxim Pilyugin

MP

8

Publications

409

Citations

8

H-Index

2009

Active since

Affiliations

University Hospital of Geneva(Current)

The University of Western Australia

University of Geneva

Erasmus MC

Institute for Respiratory Health

Maxim Pilyugin is an author at University Hospital of Geneva specializing in medicine, epigenetics, and cell biology.

ORCID

Top concepts

Publications per year

2009–2017

8

Publications

8

Histone Chaperones ASF1 and NAP1 Differentially Modulate Removal of Active Histone Marks by LID-RPD3 Complexes during NOTCH Silencing

Yuri M. Moshkin, Tsung Wai Kan, Henry Goodfellow et al. · Molecular Cell · 2009 · 163 citations · Full text

, , +12

Long non-coding RNA and microRNAs might act in regulating the expression of BARD1 mRNAs

Maxim Pilyugin, Irmgard Irminger‐Finger · The International Journal of Biochemistry & Cell Biology · 2014 · 66 citations

, , +9

HDAC Inhibitors Repress BARD1 Isoform Expression in Acute Myeloid Leukemia Cells via Activation of miR-19a and/or b

Ilaria Lepore, Carmela Dell’Aversana, Maxim Pilyugin et al. · PLoS ONE · 2013 · 43 citations · Full text

, , +15

Phosphorylation-Mediated Control of Histone Chaperone ASF1 Levels by Tousled-Like Kinases

Maxim Pilyugin, Jeroen Demmers, C. Peter Verrijzer et al. · PLoS ONE · 2009 · 41 citations · Full text

Expression of oncogenic BARD1 isoforms affects colon cancer progression and correlates with clinical outcome

Y.-Q. Zhang, Maxim Pilyugin, Doerthe Kuester et al. · British Journal of Cancer · 2012 · 34 citations · Full text

, , +11

Rows per page

1–5 of 8